课题基金 / 基金详情

Patient and Caregiver Provision of Outpatient Parenteral Antimicrobial Therapy (OPAT): A Patient-Centered Quality Improvement Initiative

Patient and Caregiver Provision of Outpatient Parenteral Antimicrobial Therapy (OPAT): A Patient-Centered Quality Improvement Initiative
为患者和护理人员提供门诊肠外抗菌治疗 (OPAT):一项以患者为中心的质量改进计划
批准号:
9900747
负责人:
Sara Condron Keller
金额:
$14.27万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-04-01 至 2021-03-31

项目摘要

项目成果

Sara Condron Keller的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
With increasing demands for cost reductions, the US healthcare system has moved many complicated medical technologies from the hospital to the home. However, to successfully use these technologies, patients and their caregivers must perform complicated medical tasks that typically would be the role of skilled inpatient nurses. One medical technology, outpatient parenteral antimicrobial therapy (OPAT), allows patients needing long-term parenteral antimicrobials to complete these regimens after discharge via venous catheters. These patients and their caregivers perform infusions and catheter care at least daily for several weeks. They are at risk of significant complications such as catheter complications, adverse drug events, and relapse of the infection. It is unclear which patient-level risk factors may affect outcomes, how patients and caregivers actually perform OPAT-related tasks, or how to improve patient/caregiver performance of OPAT-related tasks. This proposal will identify risk factors for OPAT complications and determine which processes of OPAT administration are more likely to fail. The project will engage patients, caregivers, and home health providers as key stakeholders in understanding the risk factors for poorer outcomes and how to modify these risks to successfully complete OPAT tasks, and in developing and piloting an OPAT intervention. Specific Aim 1: To create a risk score to predict the development of OPAT complications through a prospective cohort of OPAT patients discharged from two academic medical centers. A prospective cohort of OPAT patients will be used to create a risk derivation and validation cohort to develop a risk score for OPAT complications that can be used at hospital discharge to identify patients who may need additional assistance with OPAT. Specific Aim 2: To complete a proactive risk assessment that (1) identifies ways in which OPAT patients might be harmed, and (2) informs an intervention which improves safety among patients receiving OPAT. Semi-structured interviews of patients and home observations of patients and caregivers performing OPAT tasks will be used to identify hazards in OPAT performance. This information, and the risk score from Aim 1, will be presented to groups of patients and caregivers, home health nurses, and home infusion pharmacists to develop and prioritize interventions to improve the quality of OPAT care. This intervention will be piloted among a small group of home health nurses and patients to assess its feasibility and acceptability. The overall goal of this proposal is to prepare Dr. Keller for a career as an independent investigator in patient safety by using human factors engineering and stakeholder engagement to improve the quality and safety of OPAT.
期刊论文(14)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1093/ofid/ofaa178
发表时间: 2020-06-01
期刊: OPEN FORUM INFECTIOUS DISEASES
影响因子: 4.2
作者: [Keller, Sara C., Wang, Nae-Yuh, Cosgrove, Sara E.]
通讯作者: Cosgrove, Sara E.
Assessing burden of central line-associated bloodstream infections present on hospital admission.
评估入院时中心静脉导管相关血流感染的负担。
DOI: 10.1016/j.ajic.2019.08.010
发表时间: 2020
期刊: American journal of infection control
影响因子: 4.9
作者: [Leeman,Hannah, Cosgrove,SaraE, Williams,Deborah, Keller,SaraC]
通讯作者: Keller,SaraC
Implementing a Toolkit to Improve the Education of Patients on Home-Based Outpatient Parenteral Antimicrobial Therapy (OPAT).
实施工具包以改善对患者的家庭门诊肠外抗菌治疗 (OPAT) 教育。
DOI: 10.1016/j.jcjq.2022.05.008
发表时间: 2022
期刊: Joint Commission journal on quality and patient safety
影响因子: 2.3
作者: [Keller,SaraC, Salinas,Alejandra, Gurses,AyseP, Levering,Mayo, Hohl,Dawn, Hirsch,David, Grimes,Michael, Ziemba,Kaylin, Cosgrove,SaraE]
通讯作者: Cosgrove,SaraE
The Home Infusion Collaborative to Eliminate Central Line-Associated Bloodstream Infections (CLABSI)
  • 批准号:
    10457907
  • 项目类别:
  • 资助金额:
    $50.0万
  • 财政年份:
    2020
  • 负责人:
    Sara Condron Keller
  • 依托单位:
The Home Infusion Collaborative to Eliminate Central Line-Associated Bloodstream Infections (CLABSI)
  • 批准号:
    10672910
  • 项目类别:
  • 资助金额:
    $49.99万
  • 财政年份:
    2020
  • 负责人:
    Sara Condron Keller
  • 依托单位:
The Home Infusion Collaborative to Eliminate Central Line-Associated Bloodstream Infections (CLABSI)
  • 批准号:
    10099636
  • 项目类别:
  • 资助金额:
    $48.86万
  • 财政年份:
    2020
  • 负责人:
    Sara Condron Keller
  • 依托单位:
The Home Infusion Collaborative to Eliminate Central Line-Associated Bloodstream Infections (CLABSI)
  • 批准号:
    10269913
  • 项目类别:
  • 资助金额:
    $49.99万
  • 财政年份:
    2020
  • 负责人:
    Sara Condron Keller
  • 依托单位:
海外基金